Logo Logo Logo Logo Logo
  • News & Press
  • Platform
    • Vaccines
  • Team
  • Contact
  • Careers
  • News & Press
  • Platform
    • Vaccines
  • Team
  • Contact
  • Careers
colorArtboard 4AFC-COLOR
Contact Us

    | 20 South Sarah Avenue St. Louis, MO 63108
    | info@vaxnewmo.com

    About our company
    VaxNewMo
    an early stage biotechnological company developing next-generation conjugate vaccines against infectious diseases using our proprietary in vivo conjugating technology.
    • Address: 4340 Duncan, Suite 202
    • St. Louis, MO 63110
    • Email: info@vaxnewmo.com
    • © Copyright VaxNewMo
    Recent Media
    • VaxNewMo developing a vaccine for one of the world’s deadliest microbes
    • VaxNewMo publishes its platform technology manuscript in Nature Communications
    • How one St. Louis biotech startup is proving it’s the real deal
    • Check out our latest review article on glycoengineering coli for bioconjugate vaccine, therapeutic and diagnostic production
    • VaxNewMo’s Vaccine Breakthrough Published In Nature
    Newsletter

      Important Links

      FCOI  Policy